Clinical Trials

Phase 1/2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05412225 2026-02-11

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1 Recruiting

60 enrolled

Breast Neoplasms

NCT02999477 2026-01-29

A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer

Phase 1 Completed

32 enrolled 23 charts

Breast Neoplasms

NCT06459791 2026-01-29

AVATAR

Phase NA Recruiting

110 enrolled

Breast Neoplasms

NCT06860815 2026-01-28

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Phase 2 Recruiting

11 enrolled

Breast Neoplasms

NCT01494662 2026-01-23

HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

Phase 2 Completed

140 enrolled 32 charts

Breast Neoplasms

NCT04871139 2026-01-14

An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer

Phase NA Recruiting

100 enrolled

Breast Neoplasms

NCT04521764 2026-01-08

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Phase 1 Recruiting

54 enrolled

Breast Neoplasms

NCT05557877 2026-01-06

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Phase 2 Recruiting

100 enrolled

Breast Neoplasms

NCT02834494 2025-11-24

NEO-ELASTO

140 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT01093612 2025-11-14

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

18 enrolled 6 charts

Breast Neoplasms

NCT05406232 2025-08-14

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

12 enrolled

Breast Neoplasms

NCT01000883 2025-06-18

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior

10,000 enrolled

Breast Neoplasms

NCT06130826 2025-05-30

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 Recruiting

24 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT00436254 2025-04-06

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

Phase 1 Completed

66 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms

NCT03281902 2025-03-06

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

Active not recruiting

68 enrolled

Breast Neoplasms

NCT06155305 2025-01-07

ONAC

58 enrolled

Breast Neoplasms

NCT06717984 2024-12-05

AI Model for Classifying Breast Cancer From Histopathology Images

500 enrolled

Breast Neoplasms

NCT05981326 2024-08-02

NEOEPICURE

Phase NA Recruiting

300 enrolled

Breast Neoplasms

NCT03139435 2024-04-08

Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer

20 enrolled 13 charts

Phase EARLY_PHASE1 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms, Peripheral Nervous System Diseases

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT01975597 2023-09-01

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

Terminated

8 enrolled

Breast Neoplasms

NCT05703295 2023-01-30

Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients

Unknown

40 enrolled

Breast Neoplasms

NCT05619016 2022-11-30

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

Phase 2 Unknown

72 enrolled

BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms

NCT02444390 2022-09-21

SAFIR-TOR

150 enrolled

Breast Neoplasms

NCT04758416 2022-04-20

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Unknown

50 enrolled

Breast Neoplasms

NCT02681120 2021-10-14

Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancer

3 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT01023477 2021-06-29

Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)

Phase 1/2 Completed

12 enrolled 10 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00003302 2019-09-25

MRI to Detect Breast Tumors in Women

1,500 enrolled

Breast Neoplasms

NCT00003736 2019-09-24

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

200 enrolled

Breast Neoplasms

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

8 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01372579 2019-06-07

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Phase 2 Unknown

30 enrolled

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT02445482 2019-01-09

AGATA

260 enrolled

Breast Neoplasms

NCT03744273 2018-11-19

Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot Study

Phase EARLY_PHASE1 Terminated

Breast Neoplasms

NCT00651976 2018-10-15

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

213 enrolled

Breast Neoplasms

NCT00847171 2018-09-26

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Phase 2 Completed

20 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02523612 2018-07-24

NOMAT01

300 enrolled

Breast Neoplasms

NCT00088829 2018-07-11

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer

Phase 2 Terminated

22 enrolled 3 charts

BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Neoplasms

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Phase 1 Terminated

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT01024582 2017-09-27

PAPBI

139 enrolled

Breast Neoplasms

NCT00033397 2017-07-13

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

360 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT02321527 2017-06-20

Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients

21 enrolled 4 charts

Breast Neoplasms

NCT01339442 2017-01-25

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

Phase 1 Completed

31 enrolled

Breast Neoplasms

NCT00900302 2016-02-10

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

98 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Penile Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Vulvar Neoplasms, Breast Neoplasms, Male

NCT00235235 2015-12-09

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Terminated

80 enrolled

Breast Neoplasms

NCT00201773 2015-06-30

Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer

Phase 2 Completed

22 enrolled 9 charts

Breast Neoplasms

NCT00369109 2013-04-08

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

60 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00900406 2012-11-06

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant